{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "72205-085",
      "generic_name": "Tiagabine Hydrochloride",
      "labeler_name": "Novadoz Pharmaceuticals LLC",
      "brand_name": "Tiagabine Hydrochloride",
      "active_ingredients": [
        {
          "name": "TIAGABINE HYDROCHLORIDE",
          "strength": "4 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "72205-085-30",
          "description": "30 TABLET in 1 BOTTLE (72205-085-30)",
          "marketing_start_date": "20211123",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Novadoz Pharmaceuticals LLC"
        ],
        "rxcui": [
          "1299903",
          "1299909",
          "1299911",
          "1299917"
        ],
        "spl_set_id": [
          "7c034fe0-cdac-49e1-8e39-592846ea3bec"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0372205086302",
          "0372205087309",
          "0372205085305",
          "0372205084308"
        ],
        "unii": [
          "DQH6T6D8OY"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "7c034fe0-cdac-49e1-8e39-592846ea3bec",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20211123",
      "product_id": "72205-085_7c034fe0-cdac-49e1-8e39-592846ea3bec",
      "application_number": "ANDA214816",
      "brand_name_base": "Tiagabine Hydrochloride",
      "pharm_class": [
        "Anti-epileptic Agent [EPC]",
        "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
      ]
    }
  ]
}